Filing Details
- Accession Number:
- 0001104659-24-098944
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-11 16:31:34
- Reporting Period:
- 2024-09-09
- Accepted Time:
- 2024-09-11 16:31:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649904 | Rhythm Pharmaceuticals Inc. | RYTM | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645512 | A. Lynn Tetrault | 222 Berkeley Street, 12Th Floor Boston MA 02116 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-09 | 3,199 | $18.99 | 6,199 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-09-09 | 3,199 | $50.04 | 3,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-09-10 | 10,000 | $4.15 | 13,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-09-10 | 7,501 | $18.99 | 20,501 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-09-10 | 8,490 | $49.05 | 12,011 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-09-10 | 8,661 | $50.20 | 3,350 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-09-10 | 350 | $50.60 | 3,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2024-09-09 | 3,199 | $0.00 | 3,199 | $18.99 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-09-10 | 10,000 | $0.00 | 10,000 | $4.15 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-09-10 | 7,501 | $0.00 | 7,501 | $18.99 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,501 | 2031-06-08 | No | 4 | M | Direct | |
| 0 | 2032-06-07 | No | 4 | M | Direct | |
| 0 | 2031-06-08 | No | 4 | M | Direct |
Footnotes
- The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted on May 13, 2024.
- The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $50.00 to $50.25. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $48.53 to $49.52. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $49.54 to $50.50. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $50.55 to $50.71. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- The option is fully vested and exercisable.
Billionaire Hedge Funds
